MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 72 filers reported holding MUSTANG BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 986 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,375,000 | $12,420,000 | 0.88% |
| FNY Investment Advisers, LLC | 200,000 | $736,000 | 0.22% |
| 683 Capital Management, LLC | 625,000 | $2,300,000 | 0.21% |
| HIGHLAND CAPITAL MANAGEMENT LP | 350,000 | $1,288,000 | 0.08% |
| B. Riley Wealth Advisors, Inc. | 107,874 | $397,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 176,400 | $650,000 | 0.02% |
| Quinn Opportunity Partners LLC | 35,514 | $131,000 | 0.02% |
| Frontier Wealth Management LLC | 29,510 | $109,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 15,031 | $55,000 | 0.01% |
| Alyeska Investment Group, L.P. | 165,811 | $610,000 | 0.01% |